Antibody-functionalized polymer-coated gold nanoparticles targeting cancer cells: An in vitro and in vivo study

Autor: Bernard Gallez, Bernard Masereel, Olivier Feron, Linda Karmani, Vanessa Valembois, Riccardo Marega, Lionel Flamant, Davide Bonifazi, Thierry Vander Borght, Stéphane Lucas, Praveen Ganesh Nageswaran, Carine Michiels
Přispěvatelé: R., Marega, L., Karmani, L., Flamant, P., Nageswaran, V., Valemboi, B., Masereel, O., Feron, T., Borght, S., Luca, C., Michiel, B., Gallez, Bonifazi, Davide
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Biodistribution
Cancer cells
Materials science
medicine.drug_class
Allyl amine
Biodistributions
Cancer cells
Cancer-targeting
Cell lines
Epidermal growth factor receptors
Functionalizations
Gold Nanoparticles
In-vitro
In-vivo
Western blots

Cell culture
Metal nanoparticles
Monoclonal antibodies
Plasmas
Vapors

Gold
Western blots
Metal nanoparticles
Functionalizations
Cell culture
Metal nanoparticles
Monoclonal antibodies
Plasmas
Vapor

Biodistributions
Monoclonal antibody
Allylamine
In-vitro
chemistry.chemical_compound
In-vivo
In vivo
Cancer-targeting
Epidermal growth factor receptors
Materials Chemistry
medicine
Gold Nanoparticles
Epidermal growth factor receptor
biology
Allyl amine
General Chemistry
Molecular biology
Allyl amine
Biodistributions
Cancer cells
Cancer-targeting
Cell lines
Epidermal growth factor receptors
Functionalizations
Gold Nanoparticles
In-vitro
In-vivo
Western blot

chemistry
Plasmas
Colloidal gold
Vapors
biology.protein
Cell lines
Monoclonal antibodies
Cell culture
Antibody
Nanoconjugates
Zdroj: Marega, R, Karmani, L, Flamant, L, Nageswaran, P G, Valembois, V, Masereel, B, Feron, O, Vander Borght, T, Lucas, S, Michiels, C, Gallez, B & Bonifazi, D 2012, ' Antibody-functionalized polymer-coated gold nanoparticles targeting cancer cells: an in vitro and in vivo study ', Journal of Materials Chemistry, vol. 22, no. 39, pp. 21305-21312 . https://doi.org/10.1039/c2jm33482h
DOI: 10.1039/c2jm33482h
Popis: Gold nanoparticles (∼5 nm) coated with plasma-polymerized allylamine were produced through plasma vapor deposition and bioconjugated with a monoclonal antibody targeting the epidermal growth factor receptor. The resulting nanoconjugates displayed an antibody loading of about 1.7 nmol mg -1 and efficiently target epidermal growth factor receptor overexpressing cell lines, as ascertained by ELISA and Western blot assays. The in vitro targeting properties were also confirmed in vivo, where a similar biodistribution profile of what was experienced for the unconjugated antibody was observed. Thanks to the possibility of doping the gold nanoparticles with radionuclides during plasma vapor deposition, the proposed functionalization strategy represents a very suitable platform for the in vivo cancer targeting with nanosized multifunctional particles. This journal is © 2012 The Royal Society of Chemistry.
Databáze: OpenAIRE